113 related articles for article (PubMed ID: 22826825)
21. Vaginal estrogen in the treatment of genitourinary syndrome of menopause and risk of endometrial cancer: an assessment of recent studies provides reassurance.
Pinkerton JV; Kaunitz AM; Manson JE
Menopause; 2017 Dec; 24(12):1329-1332. PubMed ID: 29040220
[No Abstract] [Full Text] [Related]
22. Estrogen replacement and migraine.
MacGregor EA
Maturitas; 2009 May; 63(1):51-5. PubMed ID: 19375252
[TBL] [Abstract][Full Text] [Related]
23. Vulvovaginal complaints.
Mehta A; Bachmann G
Clin Obstet Gynecol; 2008 Sep; 51(3):549-55. PubMed ID: 18677149
[TBL] [Abstract][Full Text] [Related]
24. Effect of NFE2L2 genetic polymorphism on the association between oral estrogen therapy and the risk of venous thromboembolism in postmenopausal women.
Bouligand J; Cabaret O; Canonico M; Verstuyft C; Dubert L; Becquemont L; Guiochon-Mantel A; Scarabin PY;
Clin Pharmacol Ther; 2011 Jan; 89(1):60-4. PubMed ID: 21107315
[TBL] [Abstract][Full Text] [Related]
25. [Hormone therapy and risk for venous thromboembolism in postmenopausal women].
Lacut K; Oger E
Rev Prat; 2005 Feb; 55(4):389-92. PubMed ID: 15828617
[TBL] [Abstract][Full Text] [Related]
26. Relative value of transdermal and oral estrogen therapy in various clinical situations.
Lufkin EG; Ory SJ
Mayo Clin Proc; 1994 Feb; 69(2):131-5. PubMed ID: 8309263
[TBL] [Abstract][Full Text] [Related]
27. Effect of early estrogen replacement therapy on microvascular reactivity in patients after bilateral ovarectomy.
Prázný M; Fait T; Vrablik M
Neuro Endocrinol Lett; 2007 Aug; 28(4):496-501. PubMed ID: 17693976
[TBL] [Abstract][Full Text] [Related]
28. Genetic influence of hormone-replacement therapy on venous thromboembolism.
Sumino H; Ichikawa S; Kumakura H; Takayama Y; Kurabayashi M
Lancet; 2003 Oct; 362(9391):1242. PubMed ID: 14568759
[No Abstract] [Full Text] [Related]
29. [Hormone replacement therapy--oral and transdermal administration].
Rozmus-Warcholińska W; Skrzypulec V; Drosdzol A; Nowosielski K; Piela B; Walaszek A
Wiad Lek; 2004; 57 Suppl 1():259-61. PubMed ID: 15884252
[TBL] [Abstract][Full Text] [Related]
30. Association of oral but not transdermal estrogen therapy with enhanced platelet reactivity in a subset of postmenopausal women.
Flaumenhaft R; Nachtigall M; Lowenstein J; Nachtigall L; Nachtigall R; Nachtigall L
Menopause; 2009; 16(2):407-12. PubMed ID: 18989235
[TBL] [Abstract][Full Text] [Related]
31. Estrogen-Only Hormone Therapy and Dementia.
Glynne S
JAMA; 2024 May; 331(18):1594. PubMed ID: 38635242
[No Abstract] [Full Text] [Related]
32. [Experimental treatment of menopausal disorders by an estrogen-progestogen combination with the estrogen dominant or mixed and then a weak estrogen-progestogen combination].
Dorangeon P
Rev Fr Gynecol Obstet; 1974 Jan; 69(1):49-54. PubMed ID: 17436492
[No Abstract] [Full Text] [Related]
33. Subcutaneous hormone replacement therapy.
Tzingounis VA; Perdikaris AG; Lioutas G; Dimopoulos D
Eur J Obstet Gynecol Reprod Biol; 1993 Apr; 49(1-2):64-6. PubMed ID: 8365523
[TBL] [Abstract][Full Text] [Related]
34. Allergic contact dermatitis to testosterone and estrogen in transdermal therapeutic systems.
Ta V; Chin WK; White AA
Dermatitis; 2014; 25(5):279. PubMed ID: 25207692
[No Abstract] [Full Text] [Related]
35. Exogenous and endogenous estrogens: an appreciation of biological complexity.
Kronenberg F; Hughes C
Menopause; 1999; 6(1):4-6. PubMed ID: 10100173
[No Abstract] [Full Text] [Related]
36. The menopause: benefits and risks of hormone replacement therapy.
Gambrell RD
Compr Ther; 1994; 20(10):580-5. PubMed ID: 7859441
[No Abstract] [Full Text] [Related]
37. Low-dose estrogen therapy for menopausal women: a review of efficacy and safety.
Crandall C
J Womens Health (Larchmt); 2003 Oct; 12(8):723-47. PubMed ID: 14588124
[TBL] [Abstract][Full Text] [Related]
38. Transdermal estrogen replacement therapy. An overview of today's issues.
Alexander IM
Adv Nurse Pract; 2000 Aug; 8(8):60-3. PubMed ID: 11761525
[No Abstract] [Full Text] [Related]
39. Update on continuous estrogen-progestin replacement therapy.
Rosenfeld JA
Am Fam Physician; 1994 Nov; 50(7):1519-23, 1527-8. PubMed ID: 7976988
[TBL] [Abstract][Full Text] [Related]
40. Comparison of effects of continuous combined transdermal with oral estrogen and oral progestogen replacement therapies on serum lipoproteins and compliance.
Erenus M; Karakoç B; Gürler A
Climacteric; 2001 Sep; 4(3):228-34. PubMed ID: 11588947
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
